These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4354118)

  • 1. Complementation of theta-toxinogenicity between mutants of two groups of Clostridium perfringens.
    Higashi Y; Chazono M; Inoue K; Yanagase Y; Amano T
    Biken J; 1973 Mar; 16(1):1-9. PubMed ID: 4354118
    [No Abstract]   [Full Text] [Related]  

  • 2. Complementation in theta-toxin production between mutants of two groups of Clostridium perfringens.
    Higashi Y; Chazono M; Yanagase Y; Inoue K; Amano T
    Jpn J Med Sci Biol; 1974 Apr; 27(2):103-5. PubMed ID: 4366423
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complementation of theta-and kappa-toxin production between two group mutants of Clostridium perfringens (author's transl)].
    Higashi Y
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():160-3. PubMed ID: 194281
    [No Abstract]   [Full Text] [Related]  

  • 4. Clostridium perfringens exotoxins. III. Binding of theta-toxin to erythrocyte membrane.
    Hase J; Mitsui K; Shonaka E
    Jpn J Exp Med; 1975 Dec; 45(6):433-8. PubMed ID: 183032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies on complementation between mutants of Clostridium perfringens.
    Tatsuki T; Imagawa T; Kitajima H; Higashi Y; Chazono M; Yanagase Y; Amano T
    Biken J; 1981 Jun; 24(1-2):1-11. PubMed ID: 6272687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of acid soluble phosphate compounds from Clostridium perfringens].
    Maĭorova IP; Blagoveshchenskiĭ VA
    Biokhimiia; 1967; 32(2):329-36. PubMed ID: 4298442
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of direct sunbeams on spores of Clostridium botulinum and Clostridium perfringens of the types A].
    Mikitiuk PV
    Mikrobiol Zh; 1975; 37(2):152-4. PubMed ID: 175248
    [No Abstract]   [Full Text] [Related]  

  • 8. [On joint action of toxins of Clostridium perfringens, Cl. oedematiens and Cl. septicum and biological products of Cl. butyricum on hemolytic and lethal properties of these toxins].
    Tselukh AV
    Mikrobiol Zh; 1967; 29(2):129-33. PubMed ID: 4308693
    [No Abstract]   [Full Text] [Related]  

  • 9. [Formation of toxins by Clostridium perfringens types C and D].
    Urguev KR
    Veterinariia; 1970 Jun; 6():98-9. PubMed ID: 4320342
    [No Abstract]   [Full Text] [Related]  

  • 10. Complementation characteristics of newly isolated mutants from two groups of strains of Clostridium perfringens.
    Imagawa T; Tatsuki T; Higashi Y; Amano T
    Biken J; 1981 Jun; 24(1-2):13-21. PubMed ID: 6272688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium perfringens exotoxins. II. Purification and some properties of theta-toxin.
    Mitsui K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Oct; 43(5):377-91. PubMed ID: 4359556
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective determination of hemolytic activity of alpha or theta toxin of Clostridium perfringens.
    Akama K; Yamamoto A; Kameyama S
    Jpn J Med Sci Biol; 1969 Aug; 22(4):273-7. PubMed ID: 4311585
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the study of the toxico-infective properties of Cl. perfringens].
    Khazanova VV
    Lab Delo; 1969; 3():164-7. PubMed ID: 4185182
    [No Abstract]   [Full Text] [Related]  

  • 14. Lecithinase-negative variants of Clostridium perfringens; the identity of C. plagarum with C. perfringens.
    Nakamura S; Sakurai M; Nishida S
    Can J Microbiol; 1976 Oct; 22(10):1497-501. PubMed ID: 184898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of enterocin on Clostridium perfringens and Clostridium septicum (author's transl)].
    Krämer J; Schallehn G
    Zentralbl Bakteriol Orig A; 1974 Feb; 226(1):105-13. PubMed ID: 4152346
    [No Abstract]   [Full Text] [Related]  

  • 16. [Toxin formation by Cl. perfringens on a casein-pancreatic medium].
    Urguev KR; Kirillov LV; Liubich FD; Lavchenko EG; Panfilov ID
    Veterinariia; 1973 Feb; 49(2):39-40. PubMed ID: 4356903
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of Clostridium perfringens and its L form to bacteriocins of C. perfringens.
    Mahony DE
    Can J Microbiol; 1982 Sep; 28(9):1032-6. PubMed ID: 6291734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nitrogenous components of the nutrient medium in culturing Clostridium perfringens type D].
    Zhuravel' ESh
    Veterinariia; 1968 Jun; 45(6):25-6. PubMed ID: 4310429
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolectric focusing of Clostridium perfringens alpha- and theta- toxins.
    Smyth CJ; Arbuthnott JP
    J Gen Microbiol; 1969 Dec; 59(3):v. PubMed ID: 4313847
    [No Abstract]   [Full Text] [Related]  

  • 20. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Inoue K; Iida H
    Jpn J Med Sci Biol; 1971 Feb; 24(1):53-6. PubMed ID: 4931809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.